BIOTECHNOLOGY IN INDIA – 2013 “BIOSPECTRUM-ABLE” SURVEY

According to the eleventh annual Indian Biotech Industry survey by Biospectrum-ABLE (Association of Biotechnology Led Enterprises), the Indian biotech industry grew by 15.1 % in 2012-13, increasing its revenues from 204.4 Billion INR (Indian Rupees) to 235.24 Billion INR (3.94 B US$ - exchange rate June 2013: 1 US$ approx. 60 INR).

Figure: Indian Biotech Industry 2002-13 (in Billion INR)



INDIAN BIOTECH SECTORS

Biotech companies covered by this survey are grouped according to the following sectors:

  • BioPharma: includes vaccines, therapeutics and diagnostics
  • BioAgri: includes genetically modified seeds, molecular markers and related products
  • BioServices: includes contract research and manufacturing services (CRAMS) and clinical research services
  • BioIndustrial: includes enzymes for food, leather and textiles, pharmaceuticals, detergents and energy applications
  • BioInformatics: includes information technologies to develop tools for drug discovery, and informatics based services

MAJOR TRENDS

Based on a detailed questionnaire sent to over 200 companies, the annual survey captures the revenues – biotech products sales and service figures – or, if not available, relies on best estimates.

As in previous years, the Indian biotech industry is dominated by the BioPharma sector, which accounts for 63.5 % market share, followed by BioServices (18.5 %), BioAgri (13.6 %), BioIndustry (3.2 %) and BioInformatics (1.2 %). The differences in growth rates are significant, with BioPharma (17.7%) and BioServices (15.5%) leading the industry, followed by BioIndustrial (10.9%), BioInformatics (9.1%) and BioAgri (5.2%).

Figures for export (2,01 Billion US$) slightly exceeded domestic sales (1.93 Billion US$). Among exports, BioPharma (65 % of total exports) and BioServices (32 %) outweigh by far the other sectors with 1-2 % market share each.

The overall biotech industry registered on average 14.5 % annual growth over the last five years.
 
For details of this survey, please visit http://www.biospectrumindia.com, or http://www.ableindia.in


 

LATEST NEWS

02.06.2017 | THE DRUG DISCOVERY AND DEVELOPMENT INDUSTRY IN INDIA - TWO DECADES OF PROPRIETARY SMALL-MOLECULE R&D

A comprehensive survey of proprietary drug discovery and development efforts by Indian companies between 1994 and mid-2016, focusing on preclinical and clinical development compounds by company, therapeutic indication, mode of action, target class, and development status. The analysis includes the evolution of the overall pipeline over two decades, attrition rates, in-house developments and contributions to Western pharmaceutical pipelines through licensing agreements.

AVAILABLE OPEN ACCESS

28.01.2018 | THE STORY OF INDIAN PHARMA AND BIOTECH - BOOKS TO READ

For all those who are interested in the recent history of the pharmaceutical and biotechnology industry in India, and who want to go beyond annual reports and corporate presentations, four recently published biographies are must-reads. Whereas three books are autobiographies, a fourth one is the result of countless interviews of key players (scientists, current and past coworkers, pharma rivals, ministries, etc…), and gives unique insights into the development of biotechnology in India.

READ MORE